Merain Tablet (Calidino-genase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses (take, administer). Adjust the dose as appropriate according to age and symptoms.

This drug should not be used in patients with bleeding conditions such as immediately after a cerebral hemorrhage. This drug contains lactose, so it should not be administered to patients with genetic diseases that do not allow the breakdown of lactose. This drug contains a coloring agent, Yellow No. 5, so patients with allergies or hypersensitivity to this component should use it with caution. When taking this drug, hypersensitivity reactions such as skin rashes or itching may occur; if such symptoms appear, the use should be discontinued immediately. Cardiovascular side effects such as palpitations may occur rarely. Gastrointestinal symptoms such as stomach discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may manifest. Symptoms such as feverish sensations, headaches, drowsiness, and fatigue may also occur occasionally, so caution is required. In the elderly, bodily functions may be weakened, so special caution such as dose reduction should be taken when using this drug.

• rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• epigastric pain
• diarrhea
• constipation

This drug should be stored in a tightly closed container at a temperature between 1°C and 30°C. Storing it this way helps maintain the drug's effectiveness.

Appearance

It is an orange round enteric-coated film-coated tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle